Managing Extended Oral Anticoagulation After Unprovoked Venous Thromboembolism.

about

Managing Extended Oral Anticoagulation After Unprovoked Venous Thromboembolism.

Item

http://www.wikidata.org/entity/Q38850540

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Managing Extended Oral Anticoagulation After Unprovoked Venous Thromboembolism.

@en

type

Item

label

Managing Extended Oral Anticoagulation After Unprovoked Venous Thromboembolism.

@en

prefLabel

Managing Extended Oral Anticoagulation After Unprovoked Venous Thromboembolism.

@en

P1476

Managing Extended Oral Anticoagulation After Unprovoked Venous Thromboembolism.

@en

P2093

John R Bartholomew

http://www.w3.org/2001/XMLSchema#string

Lee Joseph

http://www.w3.org/2001/XMLSchema#string

P2860

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis

Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials

Idarucizumab for Dabigatran Reversal

Long-term management of patients after venous thromboembolism

Oral rivaroxaban for symptomatic venous thromboembolism

Cardiovascular outcomes during treatment with dabigatran: comprehensive analysis of individual subject data by treatment.

Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study.

Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association.

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.

P31

scholarly article

P356

10.1177/1074248416652236

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27250719

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation